文献速递血脂与心血管预防冠心病

乳腺动脉钙化在女性心血管风险分层中作用的综述

A Review of the Role of Breast Arterial Calcification for Cardiovascular Risk Stratification in Women.
PubMed 文献 · Circulation · 2019-01-01

心血管疾病是美国女性首要死因,缺乏可靠有效的筛查手段是改善结局的障碍之一。乳腺动脉钙化作为潜在风险分层工具,其中膜钙化与冠脉钙化或造影病变相关,40岁以上女性每年钼靶筛查可无额外成本或辐射地评估该钙化,现有证据支持普遍报告并个体化讨论以更积极干预心脏危险因素。

要点

  • 乳腺动脉钙化是女性心血管风险分层的潜在无创工具。
  • 乳腺动脉钙化与心血管危险因素或冠心病相关。
  • 现有证据支持普遍报告乳腺动脉钙化并个体化讨论。

核心结论

  • 现有证据支持普遍报告乳腺动脉钙化,并进行个体化医患讨论以更积极通过靶向药物治疗或健康生活方式改变来治疗心脏危险因素。

研究设计与样本

  • 综述,总结乳腺动脉钙化作为女性心血管风险分层工具的现有证据。

主要发现

  • 乳腺动脉钙化是动脉中膜的局限性沉积,即Mönckeberg中膜钙化性硬化,与通常与冠心病相关的内膜动脉粥样硬化过程明显不同。
  • 研究支持乳腺动脉钙化与心血管危险因素或冠心病相关,冠心病定义为计算机断层扫描上的冠状动脉钙化或血管造影上的非阻塞性和阻塞性病变或两者。
  • 多数40岁以上女性每年接受乳腺癌钼靶筛查,测量乳腺动脉钙化可能提供个体化、无创的女性心血管疾病风险分层方法,无额外成本或辐射。

临床怎么用

  • 利用40岁以上女性年度钼靶筛查评估乳腺动脉钙化,无额外成本或辐射地进行心血管风险分层。
  • 普遍报告乳腺动脉钙化,并开展个体化医患讨论以更积极治疗心脏危险因素。
  • 通过靶向药物治疗或健康生活方式改变来更积极干预心脏危险因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Cardiovascular disease continues to be the leading cause of death among women in the United States. One of the barriers to improving cardiovascular disease outcomes in women is the lack of reliable, effective screening modalities. Breast arterial calcification has emerged as a potential risk stratification tool. Localized deposition in the media of the artery, known as Mönckeberg medial calcific sclerosis, is notably different from the intimal atherosclerotic process commonly associated with coronary artery disease. Nonetheless, studies favor a correlation between breast arterial calcification and cardiovascular risk factors or coronary artery disease, defined as coronary artery calcification on computed tomography scan or both nonobstructive and obstructive lesions on angiography. Since a majority of women over the age of 40 undergo yearly breast cancer screening with mammography, measurement of breast arterial calcification may offer a personalized, noninvasive approach to risk-stratify women for cardiovascular disease at no additional cost or radiation. Mammography has the potential to alter the course of the leading cause of death in women, heart disease, through the evaluation of breast arterial calcification and identification of opportunities for prevention. Current evidence supports the universal reporting of breast arterial calcifications and personalized patient-provider discussions to more aggressively treat cardiac risk factors through targeted medical therapies or healthy lifestyle changes.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Bui QM, Daniels LB. A Review of the Role of Breast Arterial Calcification for Cardiovascular Risk Stratification in Women. Circulation. 2019. PMID: 30779650. doi:10.1161/CIRCULATIONAHA.118.038092

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。